Receptor BioLogix is Drug Discovery in United States that focus on ligand traps business. Founded in 2003. They cover business area such as developer, receptor base biological therapeutic, cancer, Hermodulins, pan-her ligand trap, durability, preclinical study, Intron Fusion Protein platform, novel alternative form-splice variant, human protein, therapeutic potential.
2003
( 21 years old in 2024 )
Ligand Traps
-
3350 West Bayshore Road
Suite 150
Palo Alto, CA 94303
United States
Private
developerreceptor base biological therapeuticcancerHermodulinspan-her ligand trapdurabilitypreclinical studyIntron Fusion Protein platformnovel alternative form-splice varianthuman proteintherapeutic potential
* We use standard office opening hours in near Receptor BioLogix's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Receptor BioLogix is Drug Discovery business from United States that founded in 2003 (21 years old in 2024), Receptor BioLogix business is focusing on Ligand Traps.
Receptor BioLogix headquarter office and corporate office address is located in 3350 West Bayshore Road Suite 150 Palo Alto, CA 94303 United States.
Receptor BioLogix was founded in United States.
In 2024, Receptor BioLogix is currently focus on ligand traps sector.
Above is snippet of Google Trends for "ligand traps" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Receptor BioLogix, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
